# SITAGLIPTIN AND METFORMIN HYDROCHLORIDE
> **ANDA217395** · Abbreviated New Drug Application (Generic) · Sponsor: MSN LABORATORIES PRIVATE LTD · Approved 2025-11-17
## Drug
- **FDA Application Number:** ANDA217395
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** SITAGLIPTIN AND METFORMIN HYDROCHLORIDE
- **Generic name:** Sitagliptin Phosphate Anhydrous, Metformin Hydrochloride
- **Active ingredients:** SITAGLIPTIN PHOSPHATE ANHYDROUS, METFORMIN HYDROCHLORIDE
- **Dosage form:** TABLET
- **Route:** —
- **Marketing status:** None (Tentative Approval)
- **Sponsor:** MSN LABORATORIES PRIVATE LTD
- **First approval:** 2025-11-17
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217395)
---
*AI Analytics · CC0 1.0*